CashuCybin Inc. Enhances Mental Health Solutions with Innovative Treatments and Research Initiatives23 days ago
FinnHubCybin Inc. Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics4 days ago
FinnHubCybin Provides Corporate Update, Highlights Positive Regulatory Signals For Psychedelic Therapeutics4 days ago
FinnHubCybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics4 days ago
FinnHubCybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference5 days ago
FinnHubCybin Applauds FDA Commissioner Dr. Martin Makary’s Call to Accelerate and Prioritize Research on Psychedelic Therapeutics28 days ago
FinnHubCybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorderabout 1 month ago
FinnHubCybin to Participate in the Alliance Global Partners Healthcare Company Showcaseabout 1 month ago